The Q3 2022 vs. Q4 2022 13F Holdings Report: Haverford Financial Services’ Portfolio Changes in Detail

Haverford Financial Services, Inc. recently released its 13F holdings report for Q3 2022 and Q4 2022 detailing changes in holdings for numerous top-performing companies in the US stock market. These changes indicate how the mutual fund’s portfolio managers have made efforts to optimize the portfolio to achieve a higher rate of return. This post takes a detailed look at the changes in the Haverford portfolio as evidenced by the report.

Introduction

Haverford Financial Services, Inc. is a wealth management company with a core focus on delivering the highest level of investment management services to its clients. The company's mutual fund, the Haverford Quality Investing Fund, provides investors with exposure to large-cap portfolios with a history of paying above-average dividends. In this post, we will be looking at the Q3 2022 vs. Q4 2022 13F holdings report for Haverford Financial Services’ mutual fund.

Main Body

The Q3 vs. Q4 13F holdings report for Haverford Financial Services provides valuable insights into its investment strategy. The report shows that the fund increased its position in 16 companies, decreased its position in 10 companies, and sold out of two companies completely.

One of the most notable increases in the fund's holdings was in Raytheon Technologies Corp (RTX). The report shows that the fund's holdings increased by 184,818 shares, from 184,924 shares in Q3 2022 to 186,651 shares in Q4 2022. The value of this holding also increased by 23.2% from $15,138,000 in Q3 2022 to $18,651,000 in Q4 2022. The fund also increased its holding in Accolade Inc (ACCD) by 1,076,863 shares, representing a 424.6% increase from 253,038 shares in Q3 2022 to 1,330,901 shares in Q4 2022.

There were some companies, however, that the fund reduced its position in. The report shows that the fund reduced its holdings in CVS Health Corporation (CVS) by 31.2% from 177,736 shares in Q3 2022 to 146,416 shares in Q4 2022. The value of this holding also decreased by 19.5% from $16,951,000 in Q3 2022 to $13,644,000 in Q4 2022. The fund also reduced its holding in UnitedHealth Group Inc (UNH) by 13.9% from 34,951 shares in Q3 2022 to 30,081 shares in Q4 2022. The value of this holding decreased by 9.7% from $17,652,000 in Q3 2022 to $15,948,000 in Q4 2022.

In addition to the changes in holdings, the report also shows that the fund sold out of its holdings in Masco Corp (MAS) and UPS Inc (UPS) completely. The fund held 33,810 shares in Masco Corp in Q3 2022, with a value of $1,579,000, but sold all of its shares in Q4 2022. The fund also held no shares of UPS Inc in Q3 2022 but held 30,728 shares in Q4 2022, with a value of $5,341,000.

Conclusion

From the Q3 vs Q4 13F Holdings report, we can see that Haverford Financial Services, Inc. has made significant adjustments to its investment portfolio. By increasing its position in companies like Raytheon Technologies Corp and Accolade Inc, the fund has likely anticipated growth in these companies or a shift in market trends. Additionally, the fund's decision to reduce its position in some companies and sell completely out of others shows that its portfolio managers are keen on delivering the best possible returns to its investors by constantly and effectively managing the portfolio. Investors in the Haverford Quality Investing Fund can expect high-quality portfolio management services that prioritize value investing strategies.